Cortexyme, Inc. (CRTX) Income Annual - Discounting Cash Flows
CRTX
Cortexyme, Inc.
CRTX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
Report Filing 2025-11-12 2025-03-24 2022-03-01 2021-03-01 2020-03-16 2018-12-31 2017-12-31
Revenue 0 0 0 0 0 0 0
Cost of Revenue 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0 0
Operating Expenses -31.77 57.28 89.94 78.89 39.17 12.12 10.37
Research & Development 84.94 18.59 60.8 61.31 30.21 10.09 9.1
Selling, General and Administrative 41.52 17.58 29.52 17.59 8.95 2.03 1.27
Other Operating Expenses -158.2 21.11 -0.373 0 0 0 0
Operating Income 31.77 -57.28 -89.94 -78.89 -39.17 -12.12 -10.37
Net Non-Operating Interest 2.45 2.93 0.62 2.04 2.19 -0.151 -1.64
Interest Income 3.11 2.93 0.62 2.04 2.19 0.806 0
Interest Expense 0.662 0 0 0 0 0.957 1.64
Equity & Other Income/(Expense) -6.98 -2.38 -0.62 0 0 -0.206 -0.222
Income Before Tax 27.24 -56.74 -89.94 -76.85 -36.98 -12.48 -12.23
Income Tax Expense 0.089 -0.087 0 0 0 0 0
Income Attributable to Non-Controlling Interest 0.278 0.174 0 0 0 0 0
Net Income 26.87 -56.83 -89.94 -76.85 -36.98 -12.48 -12.23
Depreciation and Amortization -0.166 0 0.344 0.332 0.188 0.051 0.045
EBITDA 31.61 -57.28 -89.6 -78.56 -38.98 -12.07 -10.32
Earnings Per Share (EPS) 2 -1.31 -3.02 -2.63 -1.94 -0.58 -0.57
Diluted Earnings Per Share 2 -1.31 -3.02 -2.63 -1.94 -0.58 -0.57
Weighted Average Shares Outstanding 53.95 43.26 29.77 29.18 19.06 21.55 21.55
Diluted Weighted Average Shares Outstanding 53.95 43.26 29.77 29.18 19.06 21.55 21.55
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program